コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n) and enhancer of zeste homolog 2 (EZH2) (a histone methyltransferase).
2 thus potentially connecting PRC2 to another histone methyltransferase.
3 U(Z)12 assembly with E(Z) and stimulation of histone methyltransferase.
4 thermophila, we identified TXR1, encoding a histone methyltransferase.
5 cific inhibitor (BIX-01294) of the human G9a histone methyltransferase.
6 cence-associated down-regulation of the EZH2 histone methyltransferase.
7 ities are determined by PRDM9, a DNA-binding histone methyltransferase.
8 teracts with a complex containing repressive histone methyltransferases.
9 ghting regulatory specificity for MLL family histone methyltransferases.
10 aining family, calcium channel subunits, and histone methyltransferases.
11 n, and these effects are distinct from other histone methyltransferases.
12 gh selectivity (>4500-fold) over three other histone methyltransferases.
13 tion 3-9-homologous (SUVH) group of putative histone methyltransferases.
14 bryonic fibroblasts (MEFs) lacking key H4K20 histone methyltransferases.
15 -bond and/or have steric repulsion for other histone methyltransferases.
16 = 6 nM) with broad selectivity against other histone methyltransferases.
17 st a universal regulation mechanism for most histone methyltransferases.
18 TOR pathway effectors, SWI/SNF subunits, and histone methyltransferases.
19 interacts with and activates all MLL family histone methyltransferases.
20 ations or deletions of the human Euchromatin Histone Methyltransferase 1 (EHMT1) gene are the main ca
23 the SETD1A gene, which encodes a subunit of histone methyltransferase, a finding unlikely to have oc
24 ion of AKT enhances the activity of the EZH2 histone methyltransferase, a subunit of the epigenetic r
26 function to EZH2 that is independent of its histone methyltransferase activity and reconcile how EZH
28 presence of a PRDI-BF1-RIZ1 (PR) domain with histone methyltransferase activity in the ME isoform.
29 ons tested and the EED mutation reduced PRC2 histone methyltransferase activity in vitro, demonstrati
30 riguingly, ectopic EZH2 mutant deficient for histone methyltransferase activity is also able to confe
31 Importantly, catalytic inactivation of the histone methyltransferase activity of MLL3 also severely
33 d (btd) locus in an active state through the histone methyltransferase activity of the SET1/MLL compl
34 itylation of histone 2B lysine 34 stimulates histone methyltransferase activity on nucleosomes, a fin
35 ammalian homolog, DOT1L (DOT1-Like), possess histone methyltransferase activity toward histone H3 Lys
36 at exhibited Ras-mediated dependence on PRC2 histone methyltransferase activity, a finding that is si
37 In vitro, both noncoding RNAs inhibit PRC2 histone methyltransferase activity, but, in vivo, only t
44 e capability of clemastine in elevating H3K9 histone methyltransferases activity in cultured primary
45 ve interaction of the tail peptides with G9a histone methyltransferase and histone deacetylase 1 (HDA
46 udy reveals the alteration of WNT, hedgehog, histone methyltransferase and now N-CoR pathways across
48 abolism can alter the expression of specific histone methyltransferases and acetyltransferases confer
49 unction mutations to inhibit a wide range of histone methyltransferases and are thought to promote tu
50 binding protein 2, histone deacetylases, and histone methyltransferases and demethylase in the fronta
52 lymerase chain reaction array, we found that histone methyltransferases and demethylases that regulat
53 ebellum; no changes in histone deacetylases, histone methyltransferases and demethylases, or methyl C
56 le, we will review the emerging functions of histone methyltransferases and histone demethylases in A
57 is mediated by the counteracting activity of histone-methyltransferases and histone-demethylases, is,
59 ease the catalytic activity of EZH2 and NSD2 histone methyltransferases are found in distinct subsets
62 its coactivator, the mixed-lineage leukemia histone methyltransferase, are recruited to the BRCA1, R
63 (SET domain, bifurcated 1), an H3K9-specific histone methyltransferase, as the most significantly up-
64 cilitates the binding of the trithorax group histone methyltransferases ASH1 and TRX to active genes,
65 mice carrying a hypomorphic mutation of the histone methyltransferase Ash1l [(absent, small, or home
68 eins, including histone deacetylases (HDAC), histone methyltransferases, bromodomain-containing prote
69 tro indicating that PRDM9 is a highly active histone methyltransferase catalyzing mono-, di-, and tri
71 tes: an "off state" mediated by the polycomb histone methyltransferase complex and a histone acetyltr
73 nd nascent RNAs in the nucleus and recruit a histone methyltransferase complex that catalyzes chromat
74 MEN1, which encodes menin, a component of a histone methyltransferase complex, and 43% had mutations
75 promoter by CFP1, a component of the COMPASS histone methyltransferase complex, and promoter-specific
76 omponent of the mixed-lineage leukemia (MLL) histone methyltransferase complex, and transcription fac
79 WDR5 proteins are conserved components of histone methyltransferase complexes normally associated
80 s affect alternative exon usage by targeting histone methyltransferase complexes to form localized fa
81 alian Dpy-30, a core subunit of the SET1/MLL histone methyltransferase complexes, modulates H3K4 meth
83 of zeste homolog 2 (EZH2), which encodes the histone methyltransferase component of the polycomb repr
84 atalyzed, respectively, by a conserved SUV39 histone methyltransferase, DIM-5, and a DNMT1-like cytos
85 sing small-molecule inhibitors targeting the histone methyltransferase disruptor of telomeric silenci
86 target genes in part via recruitment of the histone methyltransferase DOT1L (disruptor of telomeric
89 inhibitor studies have demonstrated that the histone methyltransferase DOT1L is required for the deve
90 t MLL-AF6 requires continued activity of the histone-methyltransferase DOT1L to maintain expression o
92 indings strongly support the contention that histone methyltransferase, DOT1L-associated epigenetic c
94 imals, the HDAC2-dependent downregulation of histone methyltransferase Ehmt2 (G9a) led to the loss of
95 with RA and coactivator Rere/Atrophin2 and a histone methyltransferase Ehmt2 to regulate embryonic sy
97 product H3K27me3, a process catalyzed by the histone methyltransferase enhancer of zeste homolog 2 (E
98 ls and activity of the epigenetic repressor, histone methyltransferase enhancer of zeste homolog 2 (E
99 is epigenetically controlled by the polycomb histone methyltransferase enhancer of zeste homolog 2 (E
102 Here, we investigated the function of the histone methyltransferase enzyme enhancer of zeste homol
103 zyme are similar to previously characterized histone methyltransferase enzymes from other organisms,
105 vely regulated by miR-101 expression include histone methyltransferase EZH2 (enhancer of zeste homolo
106 which was associated with recruitment of the histone methyltransferase Ezh2 and downregulation of the
107 inding of histone H1, thereby recruiting the histone methyltransferase EZH2 and elevating H3K27me3 le
109 , FoxP3 was inactive when complexed with the histone methyltransferase EZH2 and transcription factors
110 ivated STAT3 and increased expression of the histone methyltransferase EZH2 are independently associa
113 one morphogenetic protein signaling, and the histone methyltransferase Ezh2 have modulatory roles in
119 urther reveal a novel mechanism that reduced histone methyltransferase EZH2 leads to a lower trimethy
121 ate the epigenetic modifications mediated by histone methyltransferase EZH2 or miR-150 and thus calib
122 me3 histone mark and binding of the Polycomb histone methyltransferase Ezh2 persisted at differentiat
123 hosphorylation of Rb and release of E2F1.The histone methyltransferase EZH2 silences genes by generat
124 ylation of histone H3 lysine 27, deplete the histone methyltransferase Ezh2 specific to trimethylatio
126 between allogeneic T-cell responses and the histone methyltransferase Ezh2, which catalyzes histone
127 ow that upregulation of the Polycomb protein histone methyltransferase EZH2, which limits differentia
132 rent mutations in the gene encoding the EZH2 histone methyltransferase (EZH2), but the carcinogenic r
134 key epigenetic regulators, whether and how a histone methyltransferase forms a network with miRNAs an
135 e essential nature of cross-talk between the histone methyltransferase G9a and the demethylase Jarid1
139 ly, dyclonine also inhibited the activity of histone methyltransferase G9a, known to methylate histon
141 g KAP1, histone deacetylases HDAC1/2 and the histone methyltransferase G9a/GLP and modulates the inte
142 pigenetic regulators, such as Dnmt3l and the histone methyltransferases G9a and Prdm9, have been repo
143 B family member RelB, and RelB recruited the histone methyltransferases G9a and SETDB1 to the Il17 lo
146 was abolished in cells upon depletion of the histone methyltransferase gene SET-domain containing 2 (
149 al regulators of chromatin structure such as histone methyltransferases, histone deacetylases, or the
150 hares common structural domains, has similar histone methyltransferase (HMT) activity, and belongs in
151 ng evidence has implicated a small number of histone methyltransferase (HMT) and histone demethylase
153 We found that embryonic deletion of the histone methyltransferase (HMT) Ezh2 from all retinal pr
155 gene loci encoding adipogenesis regulators, histone methyltransferase (HMT) G9a-mediated repressive
156 Here, we used gene targeted inactivation of histone methyltransferase (HMT) multiple myeloma SET dom
158 s a member of the trithorax (TrxG) family of histone methyltransferases (HMT) that methylate H3K4 at
160 histone H4, which facilitates recruitment of histone methyltransferases (HMTases), SET8 and SUV4-20H,
161 nosyl homocysteine (SAH) detection assay for histone methyltransferases (HMTs) and its applications i
162 ct other mixed-lineage leukemia (MLL) family histone methyltransferases (HMTs), revealing a unique re
163 ding to H3K9me marks and interacting to H3K9 histone methyltransferases (HMTs), such as SUV39H1, whic
164 e defined a role for activated STAT3 and G9a histone methyltransferase in epigenetic silencing of miR
165 volves Enhancer of Zeste Homolog 2 (EZH2), a histone methyltransferase in head and neck cancers.
170 activated primary HSCs we found a number of histone methyltransferases including MLL1, MLL5, Set1 an
171 2 were inhibited by ubH2A, whereas the other histone methyltransferases, including PRC2, G9a, and Pr-
172 38, a selective inhibitor of EHMT1 and EHMT2 histone methyltransferases, induces gamma-globin express
175 eatment of cultured pancreatic islets with a histone methyltransferase inhibitor leads to colocalizat
179 creening and in vivo characterization of new histone methyltransferase inhibitors and accelerate the
180 ng histone methylation status in response to histone methyltransferase inhibitors in living animals.
182 tylase inhibitors to increase euchromatin or histone methyltransferase inhibitors to decrease heteroc
185 otein with a SET domain, also called SETDB1) histone methyltransferase is expressed in articular cart
188 of proteins associated with Set1) family of histone methyltransferases is known to activate transcri
190 rt hairpin RNAs were used to inhibit several histone methyltransferases (KMT) and histone demethylase
193 tored by mutations in the genes encoding the histone methyltransferase KYP and DNA methyltransferase
196 of histone H3K9 through the activity of the histone methyltransferase met-2 and the nuclear co-facto
197 1, LIN-13, LIN-61, LET-418/Mi-2, and H3K9me2 histone methyltransferase MET-2/SETDB1 also show functio
199 ive H3K9me2 marks, but also helps to recruit histone methyltransferase MLL1 to promote H3K4 methylati
200 novo enhancers is primarily dependent on the histone methyltransferases Mll1, Mll2/4, and Mll3 and is
201 to be due to a lack of interaction with the histone methyltransferase, MLL1, resulting in decreased
202 shown that this program is controlled by two histone methyltransferases, MLL1 and DOT1L, as deletion
203 tin remodelling genes, ARID1A and ARID1B, in histone methyltransferase MLL3, in histone deacetylase m
204 g et al. describe an unexpected role for the histone methyltransferases MLL3 and MLL4 in the repressi
205 ding more than twofold overexpression of the histone methyltransferase MLL5 and LINE-1 elements trans
206 hylation of H4K20 at DSBs is mediated by the histone methyltransferase MMSET (also known as NSD2 or W
210 Here we show that haplo-insufficiency of the histone methyltransferase myeloid-lineage leukemia (Mll2
212 iochemical purification identifies the H3K36 histone methyltransferase NSD/dMes-4 as a novel IBP cofa
213 indicate that inactivating mutations in the histone methyltransferase NSD1 define an intrinsic subty
220 mb group protein Ezh2 is a histone H3 Lys-27 histone methyltransferase orchestrating an extensive epi
224 Here, we reveal that BCL11A interacts with histone methyltransferase (PRC2) and histone deacetylase
226 L gene, which is an evolutionarily conserved histone methyltransferase, recently identified as a pote
229 Polycomb repressive complex-2 (PRC2) is a histone methyltransferase required for epigenetic silenc
230 Polycomb repressive complex-2 (PRC2) is a histone methyltransferase required for epigenetic silenc
235 X-01294 and TM2-115 inhibit malaria parasite histone methyltransferases, resulting in rapid and irrev
237 ere, we report a deletion of the Arabidopsis histone methyltransferase SDG8 in this mutant (renamed s
239 3) complex, composed of ASH-2, WDR-5 and the histone methyltransferase SET-2, regulates Caenorhabditi
240 s a PTM of dynamic microtubules and that the histone methyltransferase SET-domain-containing 2 (SETD2
243 uired for histone H3K4 methylation, both the histone methyltransferase Set1 and the E3 ubiquitin liga
245 down of either SAM synthetase (Sam-S) or the histone methyltransferase Set1 is restored to near norma
246 anges in the number of binding sites for the histone methyltransferase Set2, thereby influencing both
248 t in this paper that expression of the H3-K4 histone methyltransferase Set7 is increased when myoblas
250 he replication licensing factor CDT1 and the histone methyltransferase SET8, are targeted for proteol
251 Ott1, which associates with Hdac3 and the histone methyltransferase, Setd1b, binds to both c-Mpl R
252 to these stage-specific effects, loss of the histone methyltransferase Setd2 had robust tumor-promoti
253 oic acids 1-5 are in vitro inhibitors of the histone methyltransferase SETD8, and nahuoic acid A (1)
254 In this issue, Cuellar et al. find that the histone methyltransferase SETDB1 enables acute myeloid l
255 tinct from that in murine EC cell lines: the histone methyltransferase SETDB1 is required, but the wi
257 t Lid opposes the functions of dLsd1 and the histone methyltransferase Su(var)3-9 in promoting hetero
260 e deacetylases (HDACs) and a lysine-specific histone methyltransferase, SU(VAR)3-9, play a significan
264 ter site induces stepwise recruitment of the histone methyltransferase Suv39H1, causes local H3K9 tri
267 didate epigenetic factors and identified the histone methyltransferase SUV420H2 (KMT5C) as favoring t
268 onal activation, and DOT1L is the only known histone methyltransferase that catalyzes H3K79 methylati
271 nd siRNA knockdown studies show that EZH2, a histone methyltransferase that catalyzes trimethylation
272 dy, we investigated the role of G9a/Ehmt2, a histone methyltransferase that defines a repressive epig
274 Polycomb repressive complex 2 (PRC2) is a histone methyltransferase that is localized to thousands
275 Enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase that is overexpressed by pancr
276 ning protein 7 (PRDM7) is a primate-specific histone methyltransferase that is the result of a recent
277 ll molecule inhibitor of the DOT1L enzyme, a histone methyltransferase that methylates lysine 79 of h
279 stently decreased the expression of Prdm2, a histone methyltransferase that monomethylates histone 3
280 e recently demonstrated that WRAD is a novel histone methyltransferase that preferentially catalyzes
282 Polycomb repressive complex 2 (PRC2) is a histone methyltransferase that trimethylates H3K27, a ma
283 SETD1A is a member of trithorax-related histone methyltransferases that methylate lysine 4 at hi
284 ters of a subset of these genes by the SMYD5 histone methyltransferase through its association with N
285 DD4L and recruit enhancer of zeste homolog 2 histone methyltransferase to repress NEDD4L transcriptio
286 1 also interferes with binding of the SET7/9 histone methyltransferase to the imprinting control regi
287 omatin remodelers, histone deacetylases, and histone methyltransferases to repress transcription.
289 he H3K4 methyltransferase SMYD3 was the only histone methyltransferase upregulated upon infection.
290 quire the interaction of NKX3.1 with the G9a histone methyltransferase via the homeodomain and are me
291 otic discs 1 (ASH1), and Compass member SET1 histone methyltransferases were O-GlcNAc-modified in oga
293 YND domain containing protein 3 (SMYD3) is a histone methyltransferase, which has been implicated in
294 subunits and the transcription-coupled Set2 histone methyltransferase, which is involved in suppress
295 show that TERRA associates with SUV39H1 H3K9 histone methyltransferase, which promotes accumulation o
296 -repressor, together with HP1 and the SETDB1 histone methyltransferase, which results in transcriptio
299 y to study the global function of a specific histone methyltransferase within a multicellular organis
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。